153 related articles for article (PubMed ID: 22243289)
21. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
[TBL] [Abstract][Full Text] [Related]
22. Differentiating between endocervical glandular neoplasia and high grade squamous intraepithelial lesions in endocervical crypts: cytological features in ThinPrep and SurePath cervical cytology samples.
Thiryayi SA; Marshall J; Rana DN
Diagn Cytopathol; 2009 May; 37(5):315-9. PubMed ID: 19191292
[TBL] [Abstract][Full Text] [Related]
23. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
McCredie MR; Sharples KJ; Paul C; Baranyai J; Medley G; Jones RW; Skegg DC
Lancet Oncol; 2008 May; 9(5):425-34. PubMed ID: 18407790
[TBL] [Abstract][Full Text] [Related]
24. Invasive cervical cancer after treatment of CIN.
Herbert A; Culora G; McLean E; Kubba AA;
J Am Soc Cytopathol; 2019; 8(6):324-332. PubMed ID: 31523013
[TBL] [Abstract][Full Text] [Related]
25. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
26. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
[TBL] [Abstract][Full Text] [Related]
27. Use of the ThinPrep Imaging System for internal quality control of cervical cytology.
Heard T; Chandra A; Culora G; Gupta SS; Herbert A; Morgan M
Cytopathology; 2013 Aug; 24(4):246-53. PubMed ID: 22937891
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
29. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
30. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
31. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
32. Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experience.
Palmer TJ; Nicoll SM; McKean ME; Park AJ; Bishop D; Baker L; Imrie JE
Cytopathology; 2013 Aug; 24(4):235-45. PubMed ID: 22616770
[TBL] [Abstract][Full Text] [Related]
33. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital.
Khaengkhor P; Mairaing K; Suwannarurk K; Thaweekul Y; Poomtavorn Y; Pattaraarchachai J; Bhamarapravatana K
J Med Assoc Thai; 2011 Feb; 94(2):152-8. PubMed ID: 21534360
[TBL] [Abstract][Full Text] [Related]
35. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening.
Jeng CJ; Liang HS; Wang TY; Shen J; Yang YC; Tzeng CR
Int J Gynecol Cancer; 2003; 13(4):518-21. PubMed ID: 12911731
[TBL] [Abstract][Full Text] [Related]
36. [Study on clinical management of HPV(+)/Pap(-) during cervical cancer screening].
Huang AJ; Zhao Y; Zou XL; Yan J; Zhao C; Cui SH; Li YY; Ren LH; Li JR; Li MZ; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):745-750. PubMed ID: 29179269
[No Abstract] [Full Text] [Related]
37. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
38. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
39. Proposed Sheffield quantitative criteria in cervical cytology to assist the grading of squamous cell dyskaryosis, as the British Society for Clinical Cytology definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):179-92. PubMed ID: 16048504
[TBL] [Abstract][Full Text] [Related]
40. Review of an Irish cervical smear service.
Dolan J; Ryan E; Thornhill M; Curran B; Leader M
Ir J Med Sci; 1990 Aug; 159(8):233-6. PubMed ID: 2076943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
